AAIPharma, of Wilmington, N.C., appointed Andreas Dreps senior vice president of global clinical development services and named Ralf Wolter vice president of clinical operations, Europe...Adimab Inc., of Lebanon, N.H., appointed Guy Van Meter senior director and head of business development...Antisoma plc, of London, appointed Eric Dodd chief financial officer and board member

UCB SA, of Brussels, Belgium, appointed Michele Antonelli executive vice president of technical operations and quality assurance and named Mark McDade executive vice president of global operations

Quinnova Pharmaceuticals Inc., of Newtown, Pa., appointed Christopher Hensby senior vice president of research and development...Seattle Genetics Inc., of Bothell, Wash., named Elaine Waller senior vice president of regulatory affairs and appointed Christopher Pawlowicz senior vice president of human resources...Somnus Therapeutics Inc., of Bedminster, N.J., appointed Gary Cupit, Linda C. Hogan, David Ramsay and Jack W. Britts to its board

Prometheus Laboratories Inc., of San Diego, named Mark Spring senior vice president and chief financial officer...Targanta Therapeutics Corp., of Cambridge, Mass., appointed Stéphane Bancel and Rosemary A. Crane to its board...Trubion Pharmaceuticals Inc., of Seattle, appointed Scott C. Stromatt senior vice president and chief medical officer

Arcxis Biotechnologies, of Pleasanton, Calif., named Christine Meda president and CEO...Calibrant Biosystems, of Gaithersburg, Md., appointed James Hawkins, Bethany Mancilla and Douglas Swirsky to its business advisory board...Lipoxen plc, of London, promoted Peter Laing to chief operating officer and appointed Ajay K. Agrawal head of business development

Tengion Inc., of East Norriton, Pa., named Mark Stejbach vice president of marketing and commercial planning...TheraGenetics Ltd., of Cambridge, Mass., and London, appointed Susan E. Bromley global head of R&D and named Kenneth B. Milne UK director of R&D

PolyMedix Inc., of Radnor, Pa., elected Richard Bank and Stefan Loren to its board...PPD Inc., of Wilmington, N.C., appointed Christine Dingivan executive vice president and chief medical officer

Alverix Inc., of San Jose, Calif., named James D. Merselis president and CEO, and a member of the board of directors...Amsterdam Molecular Therapeutics, of Amsterdam, the Netherlands, appointed Janneke de Wal director global marketing and sales

Alpharma Inc., of Bridgewater, N.J., appointed Ron Warner executive vice president and chief scientific officer and named R. Scott Shively senior vice president of pharmaceutical commercial operations...Althea Technologies Inc., of San Diego, named E. J. Brandreth vice president of quality and regulatory

Javelin Pharmaceuticals Inc., of Cambridge, Mass., named Daniel Carr president and said Fred Mermelstein assumed the role of executive director...Oncothyreon Inc., of Bellevue, Wash., named Daniel K. Spiegelman and Stephen K. Burley to its board...Pantec Biosolutions AG, of Ruggell, Leichtenstein, appointed Burkhard Feurstein and Michael Armbruester to its board

Adolor Corp., of Exton, Pa., promoted Lee Techner to vice president of medical affairs and medical director...It also named Guido Magni to its board and the governance and nominating committee

VirtualHealth Technologies Inc., of Lexington, Ky., named Robert Tapales vice president of operations. Westfield Capital Management, of Boston, named Lawrence C. Fritz Life Sciences Venture Partner. WuXi PharmaTech, of Shanghai, China, appointed Peng Wang vice president of discovery biology. XTL Biopharmaceuticals Ltd., of Valley College, N.Y., appointed Laurence N. Charney to its board.

Stem Cell Therapeutics Corp., of Calgary, Alberta, named Thomas Franck vice president of commercial planning. Trius Therapeutics Inc., of San Diego, appointed Paul Truex to its board. VentiRx Pharmaceuticals Inc., of San Diego, named Elliott Grossbard to its board.

Premier Research Group plc, of Philadelphia, appointed Anthony Faragasso, executive director and global head of medical management and safety...Somnus Therapeutics Inc., of Bedminster, N.J., named Gary Cupit, Mary Osbakken, Christine Blumhardt, Linda Hogan and Anne McCormick to its executive development team

Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Georges Gemayel, CEO and member of the board...Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Raymond T. Keane vice president, general counsel and chief compliance officer...Endo Pharmaceuticals Holdings Inc., of Chadds Ford, Pa., named Blaine T. Davis vice president of investor relations and corporate communications

Sigma-Aldrich, of St. Louis, said Chief Administrative Officer and Chief Financial Officer Michael R. Hogan will retire this summer...He will become an unpaid vice president and outside director of the Sigma-Aldrich Foundation...Vyteris Inc., of Fair Lawn, N.J., appointed Haro Hartounian president and Joseph Himy chief financial officer

Dyax Corp., of Cambridge, Mass., named Mark J. Sawyer as senior vice president of process sciences and technical operations

Egenix Inc., of New York, appointed Donald C. Fresne chairman and CEO and named Daniel Petrylak chairman of its scientific advisory board...GeneNews Ltd., of Toronto, elected Harry A. Glorikian and Fran Tuttle to its board

Aegera Therapeutics Inc., of Montreal, appointed Jeremy Curnock Cook and Gary Littlejohn to its board...Aquapharm Biodiscovery Ltd., of Oban, Scotland, appointed Douglas Thomson commercial director and named Axel Kleemann to its board...Cephalon Inc., of Frazer, Pa., appointed Jerry Pappert executive vice president and general counsel